- Home
- YQ vs SCLX Comparison
YQ vs SCLX Comparison
Compare YQ & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YQ
- SCLX
- Stock Information
- Founded
- YQ 2012
- SCLX 2011
- Country
- YQ China
- SCLX United States
- Employees
- YQ N/A
- SCLX N/A
- Industry
- YQ Other Consumer Services
- SCLX Biotechnology: Pharmaceutical Preparations
- Sector
- YQ Real Estate
- SCLX Health Care
- Exchange
- YQ Nasdaq
- SCLX Nasdaq
- Market Cap
- YQ 36.7M
- SCLX 35.7M
- IPO Year
- YQ 2020
- SCLX N/A
- Fundamental
- Price
- YQ $5.81
- SCLX $14.47
- Analyst Decision
- YQ
- SCLX Buy
- Analyst Count
- YQ 0
- SCLX 2
- Target Price
- YQ N/A
- SCLX $245.00
- AVG Volume (30 Days)
- YQ 47.9K
- SCLX 297.2K
- Earning Date
- YQ 09-03-2025
- SCLX 08-13-2025
- Dividend Yield
- YQ N/A
- SCLX N/A
- EPS Growth
- YQ N/A
- SCLX N/A
- EPS
- YQ N/A
- SCLX N/A
- Revenue
- YQ $20,003,071.00
- SCLX $44,236,000.00
- Revenue This Year
- YQ N/A
- SCLX $89.26
- Revenue Next Year
- YQ N/A
- SCLX $203.95
- P/E Ratio
- YQ N/A
- SCLX N/A
- Revenue Growth
- YQ N/A
- SCLX N/A
- 52 Week Low
- YQ $1.26
- SCLX $3.60
- 52 Week High
- YQ $6.31
- SCLX $39.90
- Technical
- Relative Strength Index (RSI)
- YQ 68.92
- SCLX 39.59
- Support Level
- YQ $5.50
- SCLX $12.62
- Resistance Level
- YQ $6.31
- SCLX $15.25
- Average True Range (ATR)
- YQ 0.52
- SCLX 2.02
- MACD
- YQ 0.05
- SCLX -0.78
- Stochastic Oscillator
- YQ 79.54
- SCLX 19.91
About YQ 17 Education & Technology Group Inc.
17 Education & Technology Group Inc is an education technology company in China. It offers smart, in-school, teaching and learning SaaS offerings assist students, teachers, schoolmasters and educational authorities across China. It also offer other educational products and services that complement students' in-school learning. Geographically group operates in China.
About SCLX Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.